-
FDA approves first-ever RSV vaccine for people 60 and older
BY MELISSA PATRICK KENTUCKY HEALTH NEWS People 60 and older now have access to the first approved vaccine against respiratory syncytial virus. The vaccine, developed by GlaxoSmithKline, is called Arexvy and was approved May 3 by the Food and Drug Administration. “Today’s approval of the first RSV vaccine is an important public-health achievement to prevent
